Instructions for Authors

Clinical Nephrology appears monthly and publishes manuscripts containing original material with emphasis on the following topics: diagnosis, therapy, prophylaxis, immunology and pathophysiology of renal disease, dialysis and renal transplantation.

Submission
1. Manuscripts: All manuscripts must be submitted online at http://cn.dustri-manus.com. If assistance is needed, contact help@dustri.com.
Include a covering letter containing the declaration given below.

2. Charges: A manuscript processing fee of US$ 70.00 / € 70.00 will be charged for each manuscript submission. Payments should be made by check paid to Dustri-Verlag Dr. Karl Feistle or by Visa-, Master- or American Express Card by stating credit card number, credit card holder and expiry date in the covering letter.

3. Declaration: The covering letter must contain the statement: "The results presented in this paper have not been published previously in whole or part, except in abstract form". All authors are required to give signed consent for publication on a separate sheet together with the covering letter. (If submitting online or by email, the signature sheet may be faxed to (321)414-0219 (America) or (+49-89)6135412 (Rest of World) or uploaded as a scanned document). Possible conflicts of interest following publication must be disclosed.

4. Registration of clinical trials: Only registered trials will be accepted with the exception of long-term trials begun before 2002. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study cause and effect relationships of interventions. Trials must register at or before the onset of patient enrollment. Registries that currently meet required standards (e.g. of accessibility, information validation, comprehensive documentation) include: US National Library of Medicine, http://www.clinicaltrials.gov – The International Standard Randomised Controlled Trial Number Registry, http://www.controlled-trials.com – European Clinical Trials Database, https://eudract.emea.europa.eu/ – The National (UK) Research Register, http://www.update-software.com/national.

5. Copyright: On acceptance of a manuscript/paper for publication, the copyright is automatically transferred to the publisher. Published manuscripts or parts of them may not be translated into other languages, reproduced in any form or recorded on files or in computer systems without written permission of the publisher.


Manuscripts

1. Only original papers written in clear, concise English and not exceeding 24,000 characters with blanks including tables, illustrations and references.

2. The authors should include with the submission of the manuscript a list of 5 suggested reviewers with postal and email addresses.

3. The following sequence of arrangement is recommended: abstract, key words, introduction, methods, material or case histories, results and discussion, each section being clearly marked. The manuscripts should be typed double-spaced on one side of the paper only on consecutively numbered pages. Illustrations, legends, tables, references, abstract (1,400 or less characters with blanks) and running title (max. 80 characters) are to be submitted on separate pages. The references list, tables and figure legends should be included in the manuscript file, rather than in separate files. The abstract should precisely outline aims, material, method, results and conclusions and be structured accordingly. It should be comprehensible to readers before they read the paper. For the purpose of documentation, indicate 3 to 5 relevant key words that may or may not appear in the title. They should be given below the abstract and separated from each other by a dash (–).

4. The title should be as concise as possible and begin with the main concept in order to facilitate electronic search. The title page should present the institutions and the full postal addresses of all authors. Each author should be correctly linked to the appropriate institution by means of numerical superscripts. The author to whom correspondence should be addressed should also be stated on the title page together with fax, telephone number and e-mail address.

5. Neph-Ed/Case reports: Neph-Ed is a section devoted to manuscripts with educational value to trainees in nephrology. These include in-depth comprehensive review articles with pedagogical value, case reports and articles pertaining to novel methods of teaching and assessment in nephrology education. Case reports must be highly educational and accompanied, when appropriate, by literature reviews. They must demonstrate one or more of the following characteristics: 1) highly probable causal relationship, 2) in-depth and thorough insights into the pathophysiology of a particular disease or phenomenon, 3) a novel and unambivalent finding of important clinical value, 4) a breakthrough finding that will pave the way for further studies. A priority score will be given to case reports written by trainees in nephrology and internal medicine. Processing fees are waived for manuscripts written by a trainee as first author and accompanied by a letter of good standing from his/her training program director.

6. Acknowledgements: All support, financial or otherwise, for any work described should be acknowledged, with the exception of support from employing institutions identifiable from the title page.

Proofs
Authors will be sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned to the publisher as requested. Costs ensuing for corrections made by the author, far in excess of mistakes made by the printer, must be carried by the author. However, under certain circumstances, essential changes of an extensive nature may still be possible; this inform of a "note added in proof".

Style
For style and presentation authors should consult a recent copy of the journal. Webster’s Third New International Dictionary is the standard for spelling and compounding. See also under Uniform Requirements for Manuscripts Submitted to Biomedical Journals, http://www.icmje.org.

Illustrations and tables
Submit images and figures as jpg or tif in high resolution (300 dpi). Images should be provided together with magnification scales when appropriate and should be large enough to be legible when reproduced. All images and figures should be referred to as figures and should be numbered consecutively in the text in Arabic numerals. The legends for images should be typed on a separate sheet. Color images can be printed at author’s expense; price estimate upon request. Tables should be numbered consecutively in the text in Arabic numerals and each typed on a separate sheet. Please use only Arial font in all figures. For the labeling of graph axes use Arial 10 pt. bold.

Citation
References should be numbered consecutively using Arabic numerals in brackets [..]. The first text reference will be [1]. If a reference is repeated, it keeps the same number. The numbered references list at the end of the manuscript should correspond to the text references.
References should be limited to a critical selection. All papers quoted in text must be listed in the bibliography. Abbreviations should be made according to Index Medicus. Examples:

1. Papers published in journals:
[1] Herberth J, Monier-Faugere M-C, Mawad HW, Branscum AJ, Herberth Z, Wang G, Cantor T, Malluche HH. The 5 most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients. Clin Nephrol. 2009; 72: 5-14.

2. Books:
[1] Samtleben W, Bosch T, Schönermarck U. Nephrology in a nutshell. Deisenhofen – Orlando: Dustri; 2007.

3. Contributions in books:
[1] Luft FC. Erythropoietin and arterial hypertension. In: Hampl H, Riedel E (eds). Cardio renal anemia syndrome. Deisenhofen – Orlando: Dustri; 2009. p. 59-62.

Reprints
Corresponding authors are entitled to 5 copies of the journal free of charge. Larger quantities of reprints can be provided for a fee listed on the reprint order form to be returned with proofs.